Vaccination against the human papillomavirus as a component of the prevention of cervical dysplasia: analysis of age and regional trends in Ukraine
DOI:
https://doi.org/10.15574/HW.2025.4(179).59Keywords:
human papillomavirus, vaccination, cervical dysplasia, prevention, female population, UkraineAbstract
The introduction of vaccination against the human papillomavirus (HPV) in Ukraine remains insufficiently studied, especially taking into account age and regional characteristics. Analysis of the coverage of the female population with HPV vaccination is necessary to assess the potential impact of preventive measures on the incidence of cervical dysplasia.
Aim - to assess the age and regional characteristics of vaccination against the human papillomavirus among the female population of Ukraine in 2021-2025 and to determine their significance in the prevention of cervical dysplasia.
Materials and methods. The research material was compiled from statistical data of the National Health Service of Ukraine regarding the number of administered doses of the HPV vaccine to the female population of Ukraine in 2021-2025. The analysis was carried out taking into account age groups (0-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79 years) and administrative-territorial units. The methods of descriptive statistics, comparative and analytical analysis with an assessment of the dynamics of indicators in temporal and regional aspects were used.
Results. It was established that in 2021, vaccination against HPV among the female population of Ukraine was isolated. In 2022-2023, a gradual increase in the number of administered doses was noted, mainly in the age group of 10-19 years. The most pronounced increase in vaccination volumes was observed in 2024-2025, with the dominance of the 20-29 and 30-39 age groups. Significant regional unevenness of vaccination coverage was revealed: the highest rates were registered in the city of Kyiv and certain regions, while vaccination remained minimal or absent in a number of regions. Age groups under 9 and over 50 were characterized by consistently low rates of vaccination.
Conclusions. Vaccination against HPV in Ukraine in 2021-2025 has pronounced age and regional disparities. Insufficient coverage of prepubescent age groups limits the effectiveness of primary prevention of cervical dysplasia. The obtained data indicate the need to expand and standardize HPV immunoprophylaxis programs, taking into account the epidemiological characteristics of the regions.
The author declares no conflict of interest.
References
Chaiken SR, Bruegl AS, Caughey AB, Emerson J, Munro EG. (2023). Adjuvant Human Papillomavirus Vaccination After Excisional Procedure for Cervical Intraepithelial Neoplasia: A Cost-Effectiveness Analysis. Obstetrics and gynecology. 141(4): 756-763. https://doi.org/10.1097/AOG.0000000000005106; PMid:36897145
Gardella B, Gritti A, Soleymaninejadian E, Pasquali MF, Riemma G, La Verde M et al. (2022). New Perspectives in Therapeutic Vaccines for HPV: A Critical Review. Medicina (Kaunas, Lithuania). 58(7): 860. https://doi.org/10.3390/medicina58070860; PMid:35888579 PMCid:PMC9315585
Gonçalves CA, Pereira-da-Silva G, Silveira RCCP, Mayer PCM, Zilly A, Lopes-Júnior LC. (2024). Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review. Cancers. 16(3): 672. https://doi.org/10.3390/cancers16030672; PMid:38339423 PMCid:PMC10854525
Grimes DR. (2024). Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study. BMJ open. 14(2): e078551. https://doi.org/10.1136/bmjopen-2023-078551; PMid:38309749 PMCid:PMC10840029
Grimes DR, Corry EMA, Malagón T, ORiain C, Franco EL, Brennan DJ. (2021). Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination. JAMA network open. 4(6): e2115321. https://doi.org/10.1001/jamanetworkopen.2021.15321; PMid:34190993 PMCid:PMC8246311
Henschke N, Bergman H, Buckley BS, Crosbie EJ, Dwan K, Golder SP et al. (2025). Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination. The Cochrane database of systematic reviews. 11(11): CD015363. https://doi.org/10.1002/14651858.CD015363.pub2; PMid:41276264 PMCid:PMC12640735
Inturrisi F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, Ronco G et al. (2021). Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer. International journal of cancer. 148(2): 320-328. https://doi.org/10.1002/ijc.33207; PMid:32663316 PMCid:PMC7754437
Kondratiuk VK, Horban NIe, Koblosh ND. (2021). Modern strategies of prophylaxis of chasse of cervix of the uterus. Realities of present time (literature review). Ukrainian Journal of Perinatology and Pediatrics. 4(88): 60-65. https://doi.org/10.15574/PP.2021.88.60
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
